The Food and Drug Administration (FDA) announce the approval of Atripla, the first one-pill, once-a-day product to treat HIV/AIDS patients during a news conference in Washington, July 12, 2006 Stock Photo -
The making of the one pill—Developing single tablet regimens for HIV and for HCV - Taiyin Yang, Reza Oliyai, Kenneth M Kent, 2022